You are here
- Home
- Therapy Areas
- Cardiovascular
A Single Center, Randomized, Double-blinded, Placebo-controlled, Open-label, Positive-controlled, Four-way Crossover Study to Assess the Effect of a Single Oral Dose NKTR-118 Administration on QTc Interval Compared to Placebo, Using AVELOX (Moxifloxacin) as a Positive Control, in Healthy Male Subjects
- Disease
- cardiovascular system
- Drug Name
- NKTR 118
- Generic Name
- NKTR-118
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- I
- Start Date
- Mar 23, 2011
- Study Name
- D3820C00014
- Study Id
- D3820C00014
- ClinicalTrials.gov ID
- NCT01325415
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
